BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dickson PV, Behrman SW. Distal Cholangiocarcinoma. Surgical Clinics of North America 2014;94:325-42. [DOI: 10.1016/j.suc.2013.12.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Lopez-Aguiar AG, Maithel SK. ASO Author Reflections: Association of Perioperative Red Blood Cell Transfusion with Increased Disease Recurrence and Worse Survival After Resection of Distal Cholangiocarcinoma. Ann Surg Oncol 2019;26:654-5. [PMID: 31286311 DOI: 10.1245/s10434-019-07613-3] [Reference Citation Analysis]
2 Wu C, Zhang J, Cao X, Yang Q, Xia D. Effect of Mir-122 on Human Cholangiocarcinoma Proliferation, Invasion, and Apoptosis Through P53 Expression. Med Sci Monit 2016;22:2685-90. [PMID: 27472451 DOI: 10.12659/msm.896404] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
3 Javle M, Bekaii-Saab T, Jain A, Wang Y, Kelley RK, Wang K, Kang HC, Catenacci D, Ali S, Krishnan S, Ahn D, Bocobo AG, Zuo M, Kaseb A, Miller V, Stephens PJ, Meric-Bernstam F, Shroff R, Ross J. Biliary cancer: Utility of next-generation sequencing for clinical management. Cancer. 2016;122:3838-3847. [PMID: 27622582 DOI: 10.1002/cncr.30254] [Cited by in Crossref: 127] [Cited by in F6Publishing: 125] [Article Influence: 21.2] [Reference Citation Analysis]
4 Lee RM, Maithel SK. Approaches and Outcomes to Distal Cholangiocarcinoma.Surg Oncol Clin N Am. 2019;28:631-643. [PMID: 31472910 DOI: 10.1016/j.soc.2019.06.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
5 Danese E, Ruzzenente A, Montagnana M, Lievens PM. Current and future roles of mucins in cholangiocarcinoma-recent evidences for a possible interplay with bile acids. Ann Transl Med 2018;6:333. [PMID: 30306072 DOI: 10.21037/atm.2018.07.16] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
6 Rizzo A, Brandi G. Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review. Cancer Treat Res Commun 2021;27:100354. [PMID: 33756174 DOI: 10.1016/j.ctarc.2021.100354] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Brindley PJ, Bachini M, Ilyas SI, Khan SA, Loukas A, Sirica AE, Teh BT, Wongkham S, Gores GJ. Cholangiocarcinoma. Nat Rev Dis Primers 2021;7:65. [PMID: 34504109 DOI: 10.1038/s41572-021-00300-2] [Reference Citation Analysis]
8 Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX. Biliary tract cancer.Lancet. 2021;397:428-444. [PMID: 33516341 DOI: 10.1016/S0140-6736(21)00153-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 23.0] [Reference Citation Analysis]
9 Chen Z, Yu B, Bai J, Li Q, Xu B, Dong Z, Zhi X, Li T. The Impact of Intraoperative Frozen Section on Resection Margin Status and Survival of Patients Underwent Pancreatoduodenectomy for Distal Cholangiocarcinoma. Front Oncol 2021;11:650585. [PMID: 34012916 DOI: 10.3389/fonc.2021.650585] [Reference Citation Analysis]
10 Lopez-aguiar AG, Ethun CG, Pawlik TM, Tran T, Poultsides GA, Isom CA, Idrees K, Krasnick BA, Fields RC, Salem A, Weber SM, Martin RCG, Scoggins CR, Shen P, Mogal HD, Beal EW, Schmidt C, Shenoy R, Hatzaras I, Maithel SK. Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium. Ann Surg Oncol 2019;26:1814-23. [DOI: 10.1245/s10434-019-07306-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
11 Courtin-tanguy L, Rayar M, Bergeat D, Merdrignac A, Harnoy Y, Boudjema K, Meunier B, Sulpice L. The true prognosis of resected distal cholangiocarcinoma: Prognosis of Distal Cholangiocarcinoma. J Surg Oncol 2016;113:575-80. [DOI: 10.1002/jso.24165] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
12 Valle JW, Borbath I, Khan SA, Huguet F, Gruenberger T, Arnold D;  ESMO Guidelines Committee. Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27:v28-v37. [PMID: 27664259 DOI: 10.1093/annonc/mdw324] [Cited by in Crossref: 240] [Cited by in F6Publishing: 216] [Article Influence: 40.0] [Reference Citation Analysis]
13 Squadroni M, Tondulli L, Gatta G, Mosconi S, Beretta G, Labianca R. Cholangiocarcinoma. Crit Rev Oncol Hematol. 2017;116:11-31. [PMID: 28693792 DOI: 10.1016/j.critrevonc.2016.11.012] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 8.5] [Reference Citation Analysis]
14 Li X, Lin H, Sun Y, Gong J, Feng H, Tu J. Prognostic Significance of the Lymph Node Ratio in Surgical Patients With Distal Cholangiocarcinoma. J Surg Res 2019;236:2-11. [PMID: 30694756 DOI: 10.1016/j.jss.2018.10.044] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
15 Khan AS, Dageforde LA. Cholangiocarcinoma. Surg Clin North Am. 2019;99:315-335. [PMID: 30846037 DOI: 10.1016/j.suc.2018.12.004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 14.0] [Reference Citation Analysis]
16 Liao P, Cao L, Chen H, Pang SZ. Analysis of metastasis and survival between extrahepatic and intrahepatic cholangiocarcinoma: A large population-based study. Medicine (Baltimore) 2021;100:e25635. [PMID: 33879742 DOI: 10.1097/MD.0000000000025635] [Reference Citation Analysis]
17 Zhou W, Qian L, Rong Y, Zhou Q, Shan J, Li P, Shi L, Liu H, Sun X. Prognostic factors and patterns of recurrence after curative resection for patients with distal cholangiocarcinoma. Radiotherapy and Oncology 2020;147:111-7. [DOI: 10.1016/j.radonc.2020.03.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
18 Dasari BV, Roberts KJ, Hodson J, Stevens L, Smith AM, Hubscher SG, Isaac J, Muiesan P, Sutcliffe RP, Marudanayagam R, Mirza DF. A model to predict survival following pancreaticoduodenectomy for malignancy based on tumour site, stage and lymph node ratio. HPB (Oxford) 2016;18:332-8. [PMID: 27037202 DOI: 10.1016/j.hpb.2015.11.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
19 Wakai T, Nagahashi M, Shimada Y, Prasoon P, Sakata J. Genetic analysis in the clinical management of biliary tract cancer. Ann Gastroenterol Surg 2020;4:316-23. [PMID: 32724874 DOI: 10.1002/ags3.12334] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Wang W, Zhong W, Yuan J, Yan C, Hu S, Tong Y, Mao Y, Hu T, Zhang B, Song G. Involvement of Wnt/β-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma. Oncotarget. 2015;6:42276-42289. [PMID: 26474277 DOI: 10.18632/oncotarget.5514] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 7.3] [Reference Citation Analysis]